Nervous System Drugs Lag Behind in Development, Approvals, Tufts Reports

Drug Industry Daily
A A
Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis.

To View This Article:

Login

Subscribe To Drug Industry Daily